Ampio Pharmaceuticals, Inc. Made Headway
Fri, Dec 18, 2020 at 05:30 PM
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) rocketted at $2.41, representing a gain of 35.4%. On Thu 17 Dec 20, AMPE:NYSEMKT hit a New 2-Week High of $1.78. The stock got featured on our News Catalysts scanner on Fri 18 Dec 20 at 07:04 AM in the 'BIOTECH' category. From Thu 03 Dec 20, the stock recorded 50.00% Up Days and 72.73% Green Days
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- LFTR (LFTR:NASDAQ), 100%
- CURO Group Holdings Corp. (CURO:NYSE), 88.74%
- Mereo BioPharma Group plc (MREO:NASDAQ), 62.9%
- FGF (FGF:NASDAQ), 50.96%
- CYREN Ltd. (CYRN:NASDAQ), 50.03%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 46.92%
- FinServ Acquisition Corp. (FSRV:NASDAQ), 36.36%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 35.39%
- FireEye, Inc. (FEYE:NASDAQ), 33.73%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 29.31%